Literature DB >> 9803198

Appropriate use of antibiotics for URIs in children: Part II. Cough, pharyngitis and the common cold. The Pediatric URI Consensus Team.

S F Dowell1, B Schwartz, W R Phillips.   

Abstract

This article summarizes the principles of judicious antimicrobial therapy for three of the five conditions--cough, pharyngitis, the common cold--that account for most of the outpatient use of these drugs in the United States. The principles governing the other two conditions, otitis media and acute sinusitis, were presented in the previous issue. This article summarizes evidence against the use of antibiotic treatment for illness with cough or bronchitis in children, unless the cough is prolonged. Although empiric treatment may be started in patients with pharyngitis when streptococcal infection is suspected, the authors recommend withholding antibiotic treatment until antigen testing or culture is positive. There is never any indication for antibiotic treatment of the common cold; it is important to understand the natural history of colds, because symptoms such as mucopurulent rhinitis or cough, even when they persist for up to two weeks, do not necessarily indicate bacterial infection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9803198

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  15 in total

1.  In children with prolonged cough, does treatment with antibiotics have a better effect on cough resolution than no treatment?: Part A: Evidence-based answer and summary.

Authors:  Emily J Bailey; Ab Chang
Journal:  Paediatr Child Health       Date:  2008-07       Impact factor: 2.253

2.  Racial and Ethnic Differences in Antibiotic Use for Viral Illness in Emergency Departments.

Authors:  Monika K Goyal; Tiffani J Johnson; James M Chamberlain; T Charles Casper; Timothy Simmons; Evaline A Alessandrini; Lalit Bajaj; Robert W Grundmeier; Jeffrey S Gerber; Scott A Lorch; Elizabeth R Alpern
Journal:  Pediatrics       Date:  2017-09-05       Impact factor: 7.124

3.  Management of upper respiratory tract infections in children.

Authors:  Mf Cotton; S Innes; H Jaspan; A Madide; H Rabie
Journal:  S Afr Fam Pract (2004)       Date:  2008-03

4.  Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Marie R Griffin
Journal:  JAMA       Date:  2009-08-19       Impact factor: 56.272

5.  Parents' experiences with pediatric care at retail clinics.

Authors:  Jane M Garbutt; Kathy M Mandrell; Melissa Allen; Randall Sterkel; Jay Epstein; Katherine Kreusser; Jerome O'Neil; Blaine Sayre; Harold Sitrin; Kristin Stahl; Robert C Strunk
Journal:  JAMA Pediatr       Date:  2013-09       Impact factor: 16.193

6.  Systemic antibiotic use among children and adolescents in Germany: a population-based study.

Authors:  Jakob Holstiege; Edeltraut Garbe
Journal:  Eur J Pediatr       Date:  2013-02-10       Impact factor: 3.183

7.  Trends in antimicrobial prescribing for bronchitis and upper respiratory infections among adults and children.

Authors:  Arch G Mainous; William J Hueston; Matthew P Davis; William S Pearson
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

Review 8.  Antibiotics for prolonged wet cough in children.

Authors:  Julie M Marchant; Helen L Petsky; Peter S Morris; Anne B Chang
Journal:  Cochrane Database Syst Rev       Date:  2018-07-31

9.  Physician behaviour for antimicrobial prescribing for paediatric upper respiratory tract infections: a survey in general practice in Trinidad, West Indies.

Authors:  Shaun Mohan; Kavita Dharamraj; Ria Dindial; Deepti Mathur; Vishala Parmasad; Joseph Ramdhanie; Jason Matthew; Lexley M Pinto Pereira
Journal:  Ann Clin Microbiol Antimicrob       Date:  2004-06-14       Impact factor: 3.944

10.  A study of non-prescription usage of antibiotics in the upper respiratory tract infections in the urban population.

Authors:  Sangeeta Bhanwra
Journal:  J Pharmacol Pharmacother       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.